Trial Profile
A prospective trial to evaluate pharmacokinetics of ceftaroline fosamil single and repeated dosing in plasma and soft tissues of healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Community-acquired pneumonia; Skin and soft tissue infections
- Focus Pharmacokinetics
- 12 Apr 2016 Results of population pharmacokinetic modelling presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
- 04 Apr 2016 Results published in the Antimicrobial Agents and Chemotherapy.
- 13 Feb 2015 New trial record